Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
Diabetes Obesity and Metabolism2017Vol. 19(9), pp. 1295–1305
Citations Over TimeTop 10% of 2017 papers
Abstract
At group level, weight loss in obese and overweight patients with T2D was consistently accompanied by HbA1c reduction in a dose-dependent manner. The model developed in the present study estimates that for each kg of mean weight loss, there is a mean HbA1c reduction of 0.1 percentage points. HbA1c-lowering is greater in populations with poor glycaemic control than in well controlled populations with the same degree of weight loss. This summary of data from previous trials regarding the effect of weight reduction on HbA1c may be used to support the design and interpretation of future studies that aim to demonstrate the efficacy of weight loss interventions for T2D treatment.
Related Papers
- → Behavioral Transitions and Weight Change Patterns Within the PREMIER Trial(2011)42 cited
- → Short-term weight changes in community-dwelling older adults: the Health, Aging, and Body Composition Weight Change Substudy(2005)17 cited
- → Short-term weight changes in community-dwelling older adults: the Health, Aging, and Body Composition Weight Change Substudy(2005)24 cited
- → Patterns of Weight Change in a Commercial Weight Loss Program(2021)2 cited
- → There seem to be no benefits from periodontal treatment on glycated hemoglobin levels of patients with uncontrolled diabetes mellitus 3 months after treatment(2018)